CSL profits jump 44 per cent on vaccine demand in the pandemic

Sydney Morning Herald

17 Feb 2021 0 shares 4 views

CSL profits jump 44 per cent on vaccine demand in the pandemic

Sydney Morning Herald

Published 17 Feb 2021

Australia’s local maker of AstraZeneca Oxford’s COVID-19 jabs beat market expectations as sales of its seasonal influenza vaccines soared in the face of the coronavirus pandemic.

Full Article

CSL profits jump 44 per cent on vaccine demand in the pandemic

CSL profits jump 44 per cent on vaccine demand in the pandemic

You might like